This page lists the SEC filings reported by AUVEN THERAPEUTICS HOLDINGS LP.
| Type | Filed | Filer | Subject | Shares Owned | Percent Owned | |
|---|---|---|---|---|---|---|
| SC 13D/A | 2024-04-25 | AUVEN THERAPEUTICS HOLDINGS LP | ADC Therapeutics SA | 2,231,210 | 2.7% | EDGAR |
| SC 13D/A | 2023-04-28 | AUVEN THERAPEUTICS HOLDINGS LP | ADC Therapeutics SA | 6,330,548 | 7.9% | EDGAR |
| SC 13D/A | 2023-02-06 | AUVEN THERAPEUTICS HOLDINGS LP | ADC Therapeutics SA | 6,330,548 | 7.9% | EDGAR |
| SC 13D/A | 2022-12-23 | AUVEN THERAPEUTICS HOLDINGS LP | ADC Therapeutics SA | 18,330,548 | 23.8% | EDGAR |
| SC 13D/A | 2022-12-09 | AUVEN THERAPEUTICS HOLDINGS LP | ADC Therapeutics SA | 18,330,548 | 23.8% | EDGAR |
| SC 13D/A | 2022-12-08 | AUVEN THERAPEUTICS HOLDINGS LP | ADC Therapeutics SA | 21,418,730 | 27.8% | EDGAR |
| SC 13D/A | 2020-10-13 | AUVEN THERAPEUTICS HOLDINGS LP | ADC Therapeutics SA | 22,193,730 | 28.9% | EDGAR |
| SC 13D | 2020-05-29 | AUVEN THERAPEUTICS HOLDINGS LP | ADC Therapeutics SA | 23,593,730 | 33.4% | EDGAR |
- Form 13F-HR
- The 13F-HR report is filed quarterly to report securities held by the filer that fall under the SEC's 13F rules.
- Form SC 13D/G
- Reported by persons and groups who own 5% or more of any class of a company's outstanding shares. If the ownership changes by 1% or more, an amendment must be filed.
- Form 3, 4, and 5
- Form 3, 4, and 5 reports are filed to report insider transactions by company officers and directors, and any beneficial owners of more than ten percent of a company's shares. Form 3 is the initial report that must be filed when a person becomes an officer, director, or beneficial owner. Form 4 reports are used to report changes in ownership, while the Form 5 report is used for reporting transactions that should have been reported earlier in a Form 4 filing.